Mindimmune Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Mindimmune Therapeutics, Inc.
Quantité totale PI 4
Rang # Quantité totale PI 391 722
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 715 794

Brevets

Marques

3 0
0 0
1 0
0
 
Dernier brevet 2021 - Dendritic cell recruitment from ...
Premier brevet 2008 - 5-membered heterocyclic amides a...

Derniers inventions, produits et services

2019 Invention Benzamides-containing compounds and their use in the treatment of depression. The present invent...
2018 Invention Dendritic cell recruitment from blood to brain in neurodegenerative disease. The present disclos...
Invention Dendritic cell recruitment from blood to brain in neurodegenerative disease. The present inventio...
Invention Cyclic amines. The present invention is directed to novel cyclic amines which inhibit the P2X7 r...
Invention Cyclic amines. The present invention is directed to novel cyclic amines which inhibit the P2X7 re...
2017 Invention Benzamides-containing compounds and their use in the treatment of epilepsy. The present invention...
2016 Invention Cyclic amines. 7 receptor.
2015 Invention Benzamide-containing compounds and their use in the treatment of pain. The present invention is d...
2014 Invention 5-membered heterocyclic amides and related compounds. 5-Membered heterocyclic amides and related ...
2013 Invention Benzamides. The present invention is directed to benzamide containing compounds which inhibit the...
2008 Invention 5-membered heterocyclic amides and related compounds. 5-Membered heterocyclic amides and related...